SING GEORGE L sold REGN

November 2, 2026 · Form 4 insider transaction

SING GEORGE L sold 4,338 shares of Regeneron Pharmaceuticals, Inc. at $963.47 per share, a transaction worth $4.18M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
4,338
Price
$963.47
Total value
$4.18M
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after37,652
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents volume-weighted average price of sales of 4,338 shares of Company stock on November 2, 2026 at prices ranging from $963.00 to $963.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

View the original Form 4 on SEC EDGAR
SING GEORGE L sold REGN: November 2, 2026 | Insider Trading Screener